4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback